Specialized in research and development services to develop new solutions in the field of probiotics and other bioactive compounds with demonstrated properties for human health.
Our mission is to contribute to the improvement of human health by utilizing our talents and capabilities for probiotics and bioactive compounds research and development. Dietary supplement industries and food industry are our main partners. Our first goal is to leverage the central role of probiotics and the gut microbiota on the glycemic regulation in prediabetes. Our lead Project is a dietary supplement designed by using specific strains selected for its potential ability for long-term glycemic regulation that aims at offering a complementary strategy to people in early stages of diabetes.
Different ways to partnership with the goal to cover your specific needs. We are a B2B provider for Dietary Supplements & Food Industry.
If you want to become one of our partners, please contact us.
(+34)633 674 251
Genbioma, proven effectiveness of probiotics for glycemia regulation.
Genbioma develops its own probiotic supplements based on objective measurable criteria which are the result of research and/or trials on:
We're developing the first Probiotic supplement for prediabetic people.
Genbioma is a research platform for probiotic and bioactive compounds studies, focused on understanding its potential to improve or maintain health in target populations.
The research includes the selection, identification, scale-up and production of our patented strain collection, in vitro and in vivo pre-clinical studies in animal models as well as clinical trials in humans, to evaluate food safety and health benefits of probiotics and other bioactive compounds for specific health purposes.
Clinical trials (mainly nutritional intervention trials to prediabetic population) performed in collaboration with prestigious research centres to further develop and extend the clinical documentation and probiotic applications.
The company has one patent pending approval to protect our company intellectual property.